Methodology error, intentionally manipulated data of poor quality and perilous local level political partiality is making the life of poor miserable and proved time and again that ‘any initiative for the poor tends to be a poor initiative.’ The erroneous way of assessing multi-dimensional indicators for locating the poor without making any distinction between facilities self-created by someone against facilities created through government schemes is nothing but an attempt to hide...

-PTI The World Bank will not reduce financial assistance to India for poverty alleviation measures because of the recent official data that showed a decline in the number of poor people in the country. The international funding agency takes a long-term view on its commitments and the poverty data released on Monday will not have any bearing on that commitment, World Bank Country Head, Mr N. Roberto Zagha, told PTI on the...

-The Hindu Food subsidies for poorest will help them cope: ADB A hike in the cost of food staples like rice and wheat could push tens of millions more people into extreme poverty in the South Asian region including India, says an Asian Development Bank (ADB) report. The Manila-based lending agency, in its report “Food Price Escalation in South Asia – A Serious and Growing Concern” released on Monday, however, said that food...

One man’s fiscal problem is another man’s lifeline. Trigger happy bureaucrats and economists may love shooting down subsidies because it bloats the fiscal deficit and burdens the government but the simple fact is that in a one billion strong nation, in which nearly one in every three live below the poverty line, one needs an effective and efficient method through which privileged tax payers can support the poor. Last week, finance...

India's decision this month to produce Germany-based multinational Bayer's anti-cancer drug Nexavar, in the first use of "compulsory licensing" in South Asia, will save lives but also raises intricate questions. Under the compulsory licensing process, a government can under World Trade Organization (WTO) rules bypass a patent owner's rights after three years and order the manufacture and sale of life-saving medicines at much cheaper cost than by obtaining the medicine from...